Kimia Biosciences is currently trading at its upper limit of Rs. 25.20, up by 1.20 points or 5.00% from its previous closing of Rs. 24.00 on the BSE.
The scrip opened at Rs. 24.00 and has touched a high and low of Rs. 25.20 and Rs. 24.00 respectively. So far 1210 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 1 has touched a 52 week high of Rs. 32.70 on 30-Jun-2020 and a 52 week low of Rs. 19.05 on 02-Jan-2020.
Last one week high and low of the scrip stood at Rs. 25.20 and Rs. 22.15 respectively. The current market cap of the company is Rs. 116.81 crore.
The promoters holding in the company stood at 74.42%, while Institutions and Non-Institutions held 0.39% and 25.19% respectively.
Kimia Biosciences has been granted permission to manufacturing and marketing of new active pharmaceutical Ingredient ‘Fimasartan Potassium Trihydrate API’ by Central Drugs Standard Control Organization, Ministry of Health & Family Welfare.
Kimia Biosciences is a pharmaceutical company and the state of the art manufacturing facility is manufacturing latest Bulk Drugs and intermediates (R&D based) for India and Overseas markets.
